Antiplatelet therapy after percutaneous coronary intervention | EuroIntervention
Complex Coronary Cases - ppt download
NUEVOS DATOS CLÍNICOS DE SYNERGY™ EN MÚLTIPLES ESCENARIOS CLÍNICOS. | SHCI - Sección de Hemodinámica y Cardiología Intervencionista de la SEC (Sociedad Española de Cardiología)
EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent | tctmd.com
Primary Results of the EVOLVE Short DAPT Study | Circulation: Cardiovascular Interventions
SYNERGY™ Programa Clínico - Ensayos cortos DAPT | Boston Scientific
Primary Results of the EVOLVE Short DAPT Study | Circulation: Cardiovascular Interventions
Shortened dual antiplatelet therapy in contemporary percutaneous coronary intervention era
Two further studies support three-month DAPT following PCI
Antiplatelet Therapy in High-Bleeding Risk Patients Undergoing PCI: Walking a Tightrope
NUEVOS DATOS CLÍNICOS DE SYNERGY™ EN MÚLTIPLES ESCENARIOS CLÍNICOS. | SHCI - Sección de Hemodinámica y Cardiología Intervencionista de la SEC (Sociedad Española de Cardiología)
JCM | Free Full-Text | Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM
Dual antiplatelet therapy duration after percutaneous coronary intervention using drug eluting stents in high bleeding risk pati
ISCHEMIC RISK MATTERS - RISK STRATIFICATION IN HIGH BLEEDING RISK (HBR) PATIENTS IMPLANTED WITH THE SYNERGY STENT: A POST-HOC ANALYSIS OF THE EVOLVE SHORT DAPT STUDY | Journal of the American College
EVOLVE Short DAPT: A Single Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated with a Bioabsorbable Polymer- Ba
SOLACI | Sociedad Latinoamericana de Cardiología Intervencionista
EVOLVE Short DAPT Trial – SYNERGY Stent - Boston Scientific
Short Versus Long-Term Dual Antiplatelet Therapy in Patients at High Bleeding Risk Undergoing PCI in Contemporary Practice: A Systemic Review and Meta-analysis | Cardiology and Therapy
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis | Nature Reviews Cardiology
One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients | Journal of the American Heart Association
Julie Soldo (@SoldoJulie) / X
The Approach to the High-Risk of Bleeding patient - ppt download
